期刊文献+

基于风险的定量吸入气雾剂包装容器系统相关研究要点 被引量:2

Risk Based Key Points of Research on Packaging Container System of Metered Dose Inhaler
原文传递
导出
摘要 定量吸入气雾剂依赖于包装容器系统给药,且药品与包装容器系统发生相互作用的可能性高,故包装容器系统是影响产品质量一个风险较高的因素。在药品申请注册或者上市后发生变更时,研究者应对包装容器系统和药品之间的相互影响进行全面研究,不仅对包装容器系统与制剂的相容性进行研究,还需要结合制剂对包装容器系统的功能性以及其对制剂关键性能的影响进行研究,并且三方面的研究结果应综合考虑,用于评价包装材料对制剂质量、疗效和安全性的影响。目前很多吸入制剂品种申报时对包装容器系统的研究尚不完善,如未对包装容器系统材料进行分析,未进行全面的浸出物研究,未考察在不同温度和湿度情况下阀门系统的密封性以及对产品关键检查项目的影响等。本文结合国内外相关技术法规要求,对定量吸入气雾剂包装容器系统研究评价关注要点进行分析和总结,为吸入制剂包装容器系统相关研究工作提供参考。 Metered dose inhalers (MDI) depend on the packaging container system for drug delivery, and the possibility of interaction between drug and packaging container system is high. Therefore, packaging container system is a high risk factor affecting the quality of inhalation aerosols. Researchers should conduct a comprehensive study on the interaction between packaging container system and drug, not only the compatibility of the packaging container system and the preparation, but also the functions of the packaging container system and its impacts on the key properties of the product. The results of these studies should be considered together to assess whether the packaging material affects the quality, efficacy and safety of the formulation. At present, many studies on the packaging system of inhalations are not perfect. Some packaging container system materials have not been analyzed, comprehensive extract research has not been carried out. Some researchers did not investigate the sealing of valve system in different temperatures and humidities which will impact on key inspection items. Starting from the compositions of the packaging container system for inhalations, combined with the requirements of the relevant technical regulations at home and abroad, this paper analyzes and summarizes the sealing, performance and compatibility studies included in the evaluation of the packaging container system for MDIs, especially in view of different requirements at home and abroad. The related research work of packaging container system can provide references.
作者 张景辰 邵奇 胡玥 吴斌 陈桂良 ZHANG Jingchen;SHAO Qi;HU Yue;WU Bin;CHEN Guiliang(Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203;SPH Sine Pharmaceutical Laboratories Co., Ltd., Shanghai 201206;Shanghai Institute for Food and Drug Control, Shanghai 201203)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2019年第7期722-727,共6页 Chinese Journal of Pharmaceuticals
基金 上海市科委课题(18DZ1910602)
关键词 吸入制剂 定量吸入气雾剂 包装容器系统 inhalation preparation metered dose inhaler packaging container system
  • 相关文献

参考文献7

二级参考文献108

  • 1陈桂良,侯惠民.以氯氟烃(CFC)和氢氟烷(HFA)为抛射剂的沙丁胺醇气雾剂的特性比较[J].药物分析杂志,2006,26(1):144-147. 被引量:9
  • 2陈桂良,侯惠民.HPLC荧光检测法测定大鼠肺中沙丁胺醇浓度及其在肺部给药中的应用[J].药物分析杂志,2006,26(7):934-937. 被引量:2
  • 3陈桂良,侯惠民.吸入用气雾剂雾粒测定方法的评价[J].中国医药工业杂志,2007,38(3):194-199. 被引量:24
  • 4Agu RU, Ugwoke MI, Armand M, et al. The lung as a route for sys- temic delivery of therapeutic proteins and peptides. Respir Res,2001, 2(4) :198. 被引量:1
  • 5LIXiao-ling(李霄凌).DesignofControlledReleaseDrugDelivery Systems(控释药物传递系统的设计).Beijing(北京):ChemicalIndustrialPress(化学工业出版社),2008. 被引量:1
  • 6Antti A, Mika L, Marjut RP. Patient satisfaction with Easyhaler com- pared with other inhalation systems in the treatment of asthma : A me- ta - Analysis. Curr Ther Res ,2000,61:61273. 被引量:1
  • 7Robsamen R. Novel aerosol peptide drug delivery systems. In:Adjei AL, Gupta PK Eds. Inhalation Delivery of Therapeutic Peptides and Proteins. New York : Marcel Dekker, 1997. 722. 被引量:1
  • 8Bakand S, Hayes A, Dechsakuhhom F. Nanoparticles: a review of particle toxicology following inhalation exposure, lnhal Toxicol, 2012,24(2) :125. 被引量:1
  • 9Heinemann L, Klappoth W, Rave K, et al. Intra - Individual variabil- ity of metabolic effect of Inhaled Insulin together with an absorption enhancer. Diabetes Care,2000,23 (9) : 1343. 被引量:1
  • 10Schlesinger RB, Naumann BD, Chen LC. Physiological and histologi- cal alterations in the bronchial mucociliary clearance system of rab- bits following intermittent oral or nasal inhalation of sulfuric acid mist. J Toxicol Environ Health, 1983,12 (2 - 3 ) :441. 被引量:1

共引文献39

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部